Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-02

Clinical Trial Update: S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections [Phase 4]

View source ↗

Summary

Phase 4 trial update on Saccharomyces boulardii for prevention of antibiotic-associated diarrhea in hospitalized adults with respiratory tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Clinical Centre of Serbia | Conditions: Prevention & Control, Diarrhea Caused by Drug | Phase 4 | Status: COMPLETED